Essential Pharma Announces the Acquisition of HALDOL® HALDOL® is a first-generation ‘typical’ antipsychotic for the treatment of schizophrenia and some other psychiatric conditions The acquisition… Continue Reading
Articles
MilliporeSigma Gains Leading Perfusion Micro-Bioreactor with Erbi Biosystems Acquisition
BURLINGTON, Mass., Dec. 6, 2022 /PRNewswire/ — MilliporeSigma the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany a leading science and technology company,… Continue Reading
ADAMA to Acquire AgriNova New Zealand Ltd.
EIJING and TEL AVIV, Israel, Dec. 6, 2022 /PRNewswire/ — ADAMA Ltd. (the “Company”) (SZSE 000553), a leading global crop protection company,… Continue Reading
Solid Biosciences Announces Closing of Acquisition of AavantiBio and Concurrent $75 Million Private Placement
CHARLESTOWN, Mass., Dec. 05, 2022 (GLOBE NEWSWIRE) — Solid Biosciences Inc. (Nasdaq: SLDB), a life sciences company focused on advancing meaningful therapies… Continue Reading
Sanofi Backs Out of Revolution Partnership in Latest Cancer Cull
Sanofi has terminated its global development and commercialization pact with Revolution Medicines, Inc. for Revolution’s SHP2 inhibitor drug candidate, the California-based biotech announced Wednesday…. Continue Reading
ProSomnus® Debuts as Publicly Traded Company Focused on Disrupting Obstructive Sleep Apnea Treatment Market with Patient-preferred Precision Oral Appliance Therapy Devices
SAN FRANCISCO, Dec. 06, 2022 (GLOBE NEWSWIRE) — ProSomnus, Inc. (“the Company”), a pioneer in precision medical devices for the… Continue Reading
Integra LifeSciences Completes the Acquisition of Surgical Innovation Associates
PRINCETON, N.J., Dec. 06, 2022 (GLOBE NEWSWIRE) — Integra LifeSciences Holdings Corporation (NASDAQ:IART), a leading global medical technology company, today announced it… Continue Reading
Enzyvant Announces Merger with Altavant
CARY, N.C., Dec. 06, 2022 (GLOBE NEWSWIRE) — Enzyvant Therapeutics, Inc. and Altavant Sciences, Inc., both wholly owned subsidiaries of… Continue Reading
Inizio Acquires Evolution Road, Bolstering Evoke’s Digital Innovation and Omnichannel Offering
NEW YORK, Dec. 7, 2022 /PRNewswire/ — Inizio, a strategic partner for companies in health and life sciences, has today announced the acquisition… Continue Reading
Burke Porter Group Expands Life Sciences Capabilities with Acquisition of Quantum 3
GRAND RAPIDS, Mich., Dec. 6, 2022 /PRNewswire/ — Burke Porter Group (BPG) today announced the acquisition of Quantum 3 (Q3). Located in County… Continue Reading